heyPatient reaches Phase 2 of the Innosuisse ScaleUp Programme

Regula Spuehler
1 day ago
2 min read

We are proud to share that heyPatient has successfully qualified for Phase 2 of the Innosuisse ScaleUp Coaching programme.

With this official award, Innosuisse recognises that we meet the strict assessment criteria and belong to a selected group of Swiss start ups with exceptional growth potential.

heyPatient is an "Innousisse-Awarded Company"

A key milestone in our growth journey

The ScaleUp Coaching programme is designed for innovative, science based companies that have already established a solid market position and are ready to take the next step in their growth journey.

Qualifying for Phase 2 means:

Validation of our business model and technology foundation
Recognition of our market traction and progress
Confidence in our future growth potential

At the same time, we gain access to a tailored coaching programme with experienced experts supporting topics such as scaling, organisational development, fundraising and international expansion.

Focus on scalable growth

In this phase, our focus is clearly on scaling:

Building efficient and scalable processes
Strengthening our organisational structure
Expanding our partner ecosystem
Preparing for international growth

The programme supports us with targeted coaching and access to a strong network.

Validation of our vision

The qualification is based on clearly defined criteria, including:

Innovative and science based business model
Proven growth performance and market maturity
High growth rate and strong future potential
Defendable product and service offering
Ambitious and committed team

CEO Matthias Spuehler states: "This recognition reinforces our commitment to improving the digital patient journey and enabling healthcare organisations to deliver more efficient and patient centred services."

Looking ahead

Reaching Phase 2 of the ScaleUp Coaching programme marks an important step for heyPatient.

Our ambition remains clear: Tto further expand our leading platform for digital patient interaction in Switzerland while building the foundation for international growth.